A Fatal Case of Concurrent Disseminated Tuberculosis, Pneumocystis Pneumonia, and Bacterial Septic Shock in a Patient with Rheumatoid Arthritis Receiving Methotrexate, Glucocorticoid, and Tocilizumab: An Autopsy Report

Author:

Ohmura Shin-Ichiro1ORCID,Ishihara Ryuhei1,Mitsui Ayaka2,Otsuki Yoshiro2,Miyamoto Toshiaki1

Affiliation:

1. Department of Rheumatology, Seirei Hamamatsu General Hospital, Shizuoka, Hamamatsu, Japan

2. Department of Pathology, Seirei Hamamatsu General Hospital, Shizuoka, Hamamatsu, Japan

Abstract

Recently, treatment for rheumatoid arthritis has dramatically improved but increases the risk of bacterial and opportunistic infections. Herein, we report a fatal case of concurrent disseminated tuberculosis, pneumocystis pneumonia, and septic shock due to pyelonephritis caused by extended-spectrum β-lactamase-producing Escherichia coli in a patient with rheumatoid arthritis who received methotrexate, glucocorticoid, and tocilizumab. Despite undergoing intensive treatment, the patient developed respiratory failure and died after 7 days of admission. An autopsy indicated that pulmonary tuberculosis were the ultimate causes of death, while pyelonephritis was controlled.

Publisher

Hindawi Limited

Subject

General Agricultural and Biological Sciences

Reference28 articles.

1. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis

2. Postmarketing Surveillance of the Safety and Effectiveness of Etanercept in Japan

3. Postmarketing surveillance of tocilizumab for rheumatoid arthritis in Japan: interim analysis of 3881 patients

4. The risk of hospitalized infection in patients with rheumatoid arthritis;A. L. Smitten;Journal of Rheumatology,2008

5. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the centers for disease control and prevention, the national institutes of health, and the HIV medicine association of the infectious diseases society of America;J. E. Kaplan;Morbidity and Mortality Weekly Report,2009

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3